Patents by Inventor Derek Wheeler

Derek Wheeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220023734
    Abstract: Skateboard training devices are provided to assist all levels and ages of skateboard enthusiasts in learning tricks. The devices can comprise a deck including a core comprising a set of materials, wherein the core is partially or entirely surrounded by an outer protective material. In some aspects, the core can be made of one or more of a wood, a plastic, a metal, a composite, a fiberglass, and nylon. In some aspects, the outer protective material comprises a foam material. In some aspects, the core can comprise a foam material that is denser than an outer protective foam material.
    Type: Application
    Filed: July 22, 2021
    Publication date: January 27, 2022
    Inventors: Clayton WHEELER, Derek ZEMEN, Oriol A. Vicente
  • Patent number: 11065195
    Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: July 20, 2021
    Assignee: MC2 Therapeutics Limited
    Inventors: Derek Wheeler, David F. Steele, Michelle Georgiou, Steen Sindet-Pedersen
  • Publication number: 20210000796
    Abstract: There is provided a topical formulation comprising a nucleophile, such as amino acids and most polypetides and/or a derivative thereof, for use in the treatment or prevention of itchy dry skin caused by urea, such as in uremic pruritus, of a subject. The amino acid may be histidine and the derivative may be a histidine degradation product, a peptide of histidine, a peptide of histidine and one or more additional amino acids, and a pharmaceutically-acceptable salt of histidine.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: DRUG DELIVERY SOLUTIONS APS
    Inventors: Torkil MENNE, Johan SELMER, Jesper LANGE, Michelle GEORGIOU, Derek WHEELER, David EVANS
  • Patent number: 10806721
    Abstract: There is provided a topical formulation comprising a nucleophile, such as amino acids and most polypeptides and/or a derivative thereof, for use in the treatment or prevention of itchy dry skin caused by urea, such as in uremic pruritus, of a subject. The amino acid may be histidine and the derivative may be a histidine degradation product, a peptide of histidine, a peptide of histidine and one or more additional amino acids, and a pharmaceutically-acceptable salt of histidine.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: October 20, 2020
    Assignee: DRUG DELIVERY SOLUTIONS APS
    Inventors: Torkil Menne, Johan Selmer, Jesper Lange, Michelle Georgiou, Derek Wheeler, David Evans
  • Publication number: 20190358151
    Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.
    Type: Application
    Filed: February 27, 2019
    Publication date: November 28, 2019
    Applicant: DRUG DELIVERY SOLUTIONS LIMITED
    Inventors: Derek WHEELER, David F. Steele, Michelle Georgiou, Steen Sindet-Pedersen
  • Publication number: 20190321336
    Abstract: There is provided a topical formulation comprising a nucleophile, such as amino acids and most polypeptides and/or a derivative thereof, for use in the treatment or prevention of itchy dry skin caused by urea, such as in uremic pruritus, of a subject. The amino acid may be histidine and the derivative may be a histidine degradation product, a peptide of histidine, a peptide of histidine and one or more additional amino acids, and a pharmaceutically-acceptable salt of histidine.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 24, 2019
    Inventors: Torkil MENNE, Johan SELMER, Jesper LANGE, Michelle GEORGIOU, Derek WHEELER, David EVANS
  • Patent number: 10265265
    Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analog and at least one corticosteroid.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: April 23, 2019
    Assignee: DRUG DELIVERY SOLUTIONS LIMITED
    Inventors: Derek Wheeler, David F. Steele, Michelle Georgiou, Steen Sindet-Pedersen
  • Patent number: 8603503
    Abstract: A biliquid foam includes from 10% to 98% by weight of a non-polar liquid other than a fuel and from 2 to 88% by weight of a continuous phase polar liquid comprising a C1-C4 alcohol, a liquid polyethylene glycol, ethylene glycol or propylene glycol, or mixtures thereof, in an amount of at least 65% by weight, relative to the weight of the continuous phase, wherein the biliquid foam is stabilized with an amount of from 0.05% to 2% by weight based on the total formulation of a surfactant which is selected from castor oil/poly(alkylene glycol) adducts containing from 20 to 50 alkoxy groups, a C8-C24 fatty acid or hydrogenated castor oil/poly(alkylene glycol) adducts containing from 20 to 60 alkoxy groups, or mixtures thereof.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: December 10, 2013
    Assignee: Drug Delivery Solutions Limited
    Inventors: Monica Dias, Philip Guffogg, Derek Wheeler, Mark Whitbread-Jordan
  • Patent number: 8008356
    Abstract: A polyaphron dispersion comprising an external phase and polyaphrons having an internal phase, the internal phase comprising (i) a first phase which is liquid and (ii) a second phase which is liquid or gaseous.
    Type: Grant
    Filed: February 24, 2005
    Date of Patent: August 30, 2011
    Assignee: Drug Delivery Solutions Limited
    Inventors: Andrew Childs, Derek Wheeler
  • Publication number: 20100093676
    Abstract: A topical composition comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion and at least one vitamin D or vitamin D analogue.
    Type: Application
    Filed: March 14, 2008
    Publication date: April 15, 2010
    Inventors: Derek A. Wheeler, David F. Steele
  • Publication number: 20080234239
    Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 25, 2008
    Inventors: Derek Wheeler, David F. Steele, Michelle Georgiou, Steen Sindet-Pedersen
  • Publication number: 20080227759
    Abstract: A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.
    Type: Application
    Filed: September 27, 2007
    Publication date: September 18, 2008
    Inventors: Derek Wheeler, Steen Sindet-Pedersen, David F. Steele, Michelle Georgiou
  • Publication number: 20070190088
    Abstract: A polyaphron dispersion comprising an external phase and polyaphrons having an internal phase, the internal phase comprising (i) a first phase which is liquid and (ii) a second phase which is liquid or gaseous.
    Type: Application
    Filed: February 24, 2005
    Publication date: August 16, 2007
    Inventors: Andrew Childs, Derek Wheeler
  • Publication number: 20070161527
    Abstract: A solid composition comprising oil core aphrons dispersed in a solid surfactant.
    Type: Application
    Filed: January 18, 2005
    Publication date: July 12, 2007
    Inventors: Anthony Mercurio, Derek Wheeler
  • Publication number: 20070071684
    Abstract: A method of coating the surface of a substrate which comprises the steps of: i) contacting the surface with a polymerisable mixture comprising one or more polymerisable components and containing suspended droplets of a biliquid foam or of a high internal oil phase emulsion, the said droplets being stabilised by a non-reactive surfactant; and ii) polymerising the coating to form a polymer comprising the droplets entrapped therein.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 29, 2007
    Inventors: Nigel Crutchley, James Guthrie, Derek Wheeler, Stephen Lenon
  • Publication number: 20060239947
    Abstract: A biliquid foam comprising from 10% to 98% by weight of a non-polar liquid other than a fuel and from 2 to 88% by weight of a continuous phase polar liquid comprising a C1-C4 alcohol, a liquid polyethylene glycol, ethylene glycol or propylene glycol, or mixtures thereof, in an amount of at least 65% by weight, relative to the weight of the continuous phase, wherein the biliquid foam is stabilized with an amount of from 0.05% to 2% by weight based on the total formulation of a surfactant which is selected from castor oil/poly(alkylene glycol) adducts containing from 20 to 50 alkoxy groups, a C8-C24 fatty acid or hydrogenated castor oil/poly(alkylene glycol) adducts containing from 20 to 60 alkoxy groups, or mixtures thereof. A stable dispersion having a content of at least 65% by weight with regard to C1-C4 alcohol, liquid polyethylene glycol, ethylene glycol or propylene glycol which dispersion comprises from 1-80% by weight of a biliquid foam and from 99-20% by weight of an aqueous gel.
    Type: Application
    Filed: July 30, 2004
    Publication date: October 26, 2006
    Inventors: Monica Dias, Philip Guffogg, Derek Wheeler, Mark Whitebread-Jordan
  • Publication number: 20060228408
    Abstract: An oral drug delivery system which comprises a biliquid foam comprising: from 1 to 20% by weight of a continuous hydrophilic phase, from 70 to 98% by weight of a pharmaceutically acceptable oil which forms a discontinuous phase, the said pharmaceutically acceptable oil having dissolved or dispersed therein a poorly water-soluble drug in an amount of from 0.1 to 20% by weight and the biliquid foam including therein from 0.5 to 10% by weight of a surfactant to enable the formation of a stable biliquid foam, all percentages being based upon the total weight of the formulation.
    Type: Application
    Filed: July 30, 2004
    Publication date: October 12, 2006
    Inventors: William Charman, Monica Dias, Michelle Georgiou, Philip Guffogg, Christopher Porter, Colin Pouton, Fraser Steele, Derek Wheeler
  • Publication number: 20050097812
    Abstract: A fuel composition which comprises a biliquid foam consisting of from 10% to 97.5% by weight of non-coalescing droplets of a non-polar liquid comprising a petroleum derivative, paraffin or a liquid halogenated hydrocarbon and from 2 to 87% by weight of a continuous phase polar liquid comprising a C1-C3 alcohol, a C4 alcohol containing at least two hydroxy groups, or ethylene glycol, or mixtures thereof, in an amount of from 60% to 100% by weight thereof, wherein the biliquid foam is stabilized with an amount of from 0.5 to 3.0% by weight based on the total formulation of a surfactant which is selected from castor oil/poly(alkylene glycol) adducts containing from 20 to 50 alkoxy groups, or hydrogenated castor oil/poly(alkylene glycol) adducts containing from 20 to 60 alkoxy groups, or mixtures thereof.
    Type: Application
    Filed: January 31, 2003
    Publication date: May 12, 2005
    Applicant: DISPERSE LIMITED
    Inventors: Philip Guffogg, Stephen Lenon, Derek Wheeler
  • Publication number: 20050049315
    Abstract: A method for the preparation of a biliquid foam which does not rely upon the initial formation of a gas foam, in which a stirrer having a single or a multiplicity of blades is used, the stirrer being operated in a manner such that at least one part of the stirrer mechanism breaks the interface between the continuous polar phase used to form the biliquid foam and the air, the non-polar phase being added dropwise at least initially whilst stirring the continuous polar phase and the rate of addition of the non-polar phase being controlled so that a biliquid foam composition is formed.
    Type: Application
    Filed: January 31, 2003
    Publication date: March 3, 2005
    Inventors: Philip Guffogg, Derek Wheeler